Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases
Clinical trial NCT03310008 · UNKNOWN
Trial details
- NCT number
- NCT03310008
- Sponsor
- Celyad Oncology SA
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-07
- Primary completion
- 2021-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.